Future prospects of nanoparticles on brain targeted drug delivery

Journal of Neuro-Oncology

Volumn 93, Issue 2, 2009, Pages 285-286

  Chakraborty, C ^a,b   Sarkar, B ^c   Hsu, C H ^b   Wen, Z H ^b   Lin, C S ^b   Shieh, P C ^d  

^a IILM Academy of Higher Learning   (India)

^b NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^c AMITY UNIVERSITY   (India)

^d TAJEN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACRYLIC ACID DERIVATIVE; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; CELL PENETRATING PEPTIDE; DIPEPTIDE; DOXORUBICIN; IRON CHELATING AGENT; KYTORPHIN; LACTOFERRIN; LEUCINE ENKEPHALIN[2 DEXTRO ALANINE 6 ARGININE]; LIPOSOME; LOPERAMIDE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY OX26; MRZ 2576; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NANOPARTICLE; NEUROPEPTIDE; POLYBUTYLCYANOACRYLIC ACID; POLYMER; POLYSORBATE 80; TITANIUM DIOXIDE; TUBOCURARINE CHLORIDE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; BIODEGRADABILITY; BLOOD BRAIN BARRIER; BRAIN DISEASE; BRAIN TUMOR; CENTRAL NERVOUS SYSTEM; DRUG ADSORPTION; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG TARGETING; ENDOTHELIUM CELL; ENZYME ACTIVITY; HUMAN; LETTER; NEUROLOGIC DISEASE; TIGHT JUNCTION; TRANSCYTOSIS;

BLOOD-BRAIN BARRIER; BRAIN; BRAIN NEOPLASMS; DRUG DELIVERY SYSTEMS; HUMANS; NANOPARTICLES;

EID: 67349164038     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-008-9759-2     Document Type: Letter

References (20)

1. Chen Y, Dalwadi G, Benson HAE (2004) Drug delivery across the blood-brain barrier. Curr Drug Deliv 1:361-376. doi: 10.2174/ 1567201043334542
2. Kreuter J (2001) Nanoparticulate systems for brain delivery of drugs. Adv Drug Deliv Rev 47:65-81. doi: 10.1016/S0169-409X(00)00122-8
3. Lockman PR, Mumper RJ, Khan MA, Allen DD (2002) Nanoparticle technology for drug delivery across the blood brain barrier. Drug Dev Ind Pharm 28:1-13. doi: 10.1081/DDC-120001481
4. Deeken JF, Löscher W (2007) The blood-brain barrier and cancer: transporters, treatment and Trojan horses. Clin Cancer Res 13:1663-1674. doi: 10.1158/1078-0432.CCR-06-2854
5. Liu G et al (2006) Nanoparticle iron chelators: A new therapeutic approach in Alzheimer disease and other neurologic disorders associated with trace metal imbalance. Neurosci Lett 406:189-193. doi: 10.1016/ j.neulet.2006.07.020
6. Calvo P, Bruno G, Iršne B, Corinne L et al (2001) PEGylated polycyanoacrylate nanoparticles as vector for drug delivery in prion diseases. J Neurosci Methods 111:151-156. doi: 10.1016/ S0165-0270(01)00450-2
7. Kreuter J (2004) Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain. J Nanosci Nanotechnol 4:484-488. doi: 10.1166/jnn.2003.077
8. Pardridge WM (2002) Drug and gene targeting to the brain with molecular Trojan horses. Nat Rev Drug Discov 1:131-139. doi: 10.1038/nrd725
9. Ji B, Maeda J, Higuchi M, Inoue K, Akita H, Harashima H, Suhara T (2006) Pharmacokinetics and brain uptake of lactoferrin in rats. Life Sci 78:851-855. doi: 10.1016/j.lfs.2005.05.085
10. Scherrmann JM, Temsamani J (2005) The use of Pep: Trans vectors for the delivery of drugs into the central nervous system. Int Congr Ser 1277:199-211. doi: 10.1016/j.ics.2005.02.023
11. Gabathuler R, Arthur G, Kennard M, Chen Q, Tsai S, Yang J, Schoorl W, Vitalis TZ, Jefferies WA (2005) Development of a potential protein vector (NeuroTrans) to deliver drugs across the bloodbrain barrier. Int Congr Ser 1277:171-184
12. Pardridge WM (2005) Drug and gene targeting to the brain via blood-brain barrier receptor-mediated transport systems. Int Congr Ser 1277:49-62. doi: 10.1016/j.ics.2005.02.011
13. Olivier JC (2005) Drug transport to brain with targeted nanoparticles. NeuroRx 2:108-119. doi: 10.1602/neurorx.2.1.108
14. Sun W, Xie C, Wang H, Hu Y (2004) Specific role of polysorbate 80 coating on the targeting of nanoparticles to the brain. Biomaterials 25:3065-3071. doi: 10.1016/j.biomaterials.2003.09.087
15. Ringe K, Walz CM, Sabel BA (2004) Nanoparticle drug delivery to the brain. Encyclopedia of Nanoscience and Nanotechnology 7:91-104
16. Alyautdin RN, Tezikov EB, Ramge P, Kharkevich DA, Begley DJ (1998) Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: An in situ brain perfusion study. J Microencapsul 15:67-74. doi: 10.3109/ 02652049809006836
17. Michaelis K, Hoffmann MM, Dreis S et al (2006) Covalent linkage of Apolipoprotein E to albumin nanoparticles strongly enhances drug transport into the brain. J Pharmacol Exp Ther 317:1246-1253. doi: 10.1124/jpet.105.097139
18. Dreher KL (2004) Health and environmental impact of nanotechnology: toxicological assessment of manufactured nanoparticle s. Toxicol Sci 77:3-5. doi: 10.1093/toxsci/kfh041
19. Lon TC, Saleh N, Tilton RD, Lowry GV, Veronesi B (2006) Titanium Dioxide (P25) produces reactive oxygen species in immortalized brain microglia (BV2): Implications for nanoparticle neurotoxicity. Environ Sci Technol 40:4346-4352. doi: 10.1021/es060589n
20. Kaur IP, Bhandari R, Bhandari S, Kakkar V (2008) Potential of solid lipid nanoparticles in brain targeting. J Control Release 127:97-109. doi: 10.1016/j.jconrel.2007.12.018